Zoya Demidenko https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0026126


[ Follow Ups ] [ Post Followup ] [ WWWBoard ]

Posted by LincolnRam on March 25, 2026 at 11:26:36:

In Reply to: Ñòàòüÿ ñ çàõâàòûâàþùèì è ïîëåçíûì êîíòåíòîì posted by JosephUrisk on February 19, 2026 at 15:39:56:

Zoya Demidenko: Researcher in Oncology Studies
Zoya Demidenko is a notable scientist associated with the Department of Cell Stress Research at Roswell Park Cancer Institute in Buffalo, New York. Before that, she worked at the National Institutes of Health and New York Medical College, building a strong base in life science research.
Demidenko's scholarly contributions spans multiple key domains, including the PI3K/AKT/mTOR signaling cascade, cellular cycle regulation, biological aging, and tumor biology. Currently, she has written more than 46 scientific papers, which have received upwards of 4,100 mentions — a reflection to the influence of her research.
One of her most significant achievements involves elucidating the processes of biological cell aging. Her work revealed that when the cell cycle is blocked but cellular expansion persists, cells enter senescence. Significantly, Zoya Demidenko demonstrated that this process can be inhibited by medication using compounds such as mTOR inhibitors.
Zoya Demidenko has additionally brought greatly to tumor management investigation, notably in the field of selective cell protection — a strategy aimed at shielding normal tissue from chemotherapy whilst leaving malignant cells exposed. This method offers major hope for diminishing the adverse effects of oncological therapy.
Throughout her professional journey, Demidenko has partnered with leading investigators worldwide, including Dr. Mikhail Blagosklonny. Her publications can be found in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Possessing an h-index of 33, Zoya Demidenko is recognized as a widely cited voice in current oncological science, with her discoveries go on to influence our comprehension of the way cells age, respond to treatment, and the ways in which malignant disease might be more effectively combated.
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPAMED%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMED%20L130000429680&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord



Follow Ups:



Post a Followup

Name:
E-Mail:

Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL:


[ Follow Ups ] [ Post Followup ] [ WWWBoard ]